GLP-1 drugs have rapidly revolutionized the treatment of Type 2 diabetes and obesity, with promising future applications for other medical problems, including addiction, on the horizon
100 mg/Kg) compared with untreated atherosclerotic mice
Herman RJ, Hayes MR, Audrain-McGovern J, Ashare RL, Schmidt HD
Combining semaglutide with vitamin B12 is a wonderfully thoughtful strategy
Endnotes: The efficacy estimand represents efficacy had all randomized participants remained on study intervention (with possible dose interruptions and modifications) without initiating prohibited weight management treatments (and glycemic rescue therapy for glycemic endpoints only)
This new study may provide important insights into how a semaglutide like Ozempic can affect vision outcomes in patients with diabetes